Datavault AI Inc.
For the period ended Jun 30, 2025. Filed Aug 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 19, 2025
DVLT$0.06+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (Deficit)
For the three and six months ended June 30, 2025 and 2024
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · · · · · · · Total | ||||||||||||||||||||
| · · Convertible Preferred Stock · · · Common Shares · · Additional · · Accumulated · · Stockholders’ | ||||||||||||||||||||
| · Shares · Amount · Shares · Amount · Paid-in Capital · Deficit · Equity (Deficit) | ||||||||||||||||||||
| Balance as of December 31, 2024 | — | | $— | | 52,034,060 | | $5 | | $384,172 | | $(298,451) | | $85,726 | |||||||
| Stock-based compensation | | — | | | — | | | 5,986,893 | | | — | | | 648 | | | — | | | 648 |
| Issuance of common stock in connection with the February Offering | | — | | | — | | | 4,757,126 | | | 1 | | | 4,859 | | | — | | | 4,860 |
| Issuance of common stock in connection with warrant exercise | — | | — | | 3,246,111 | | — | | — | | — | | — | |||||||
| Conversion of liability warrants to equity warrants | | — | | | — | | | — | | | — | | | 15 | | | — | | | 15 |
| Net loss | | — | | | — | | | — | | | — | | | — | | | (9,563) | | | (9,563) |
| Balance as of March 31, 2025 | | — | | | — | | | 66,024,190 | | $6 | | $389,694 | | $(308,014) | | $81,686 | ||||
| Stock-based compensation | | — | | | — | | | 3,701,197 | | | — | | | 1,151 | | | — | | | 1,151 |
| Issuance of common stock in connection with warrant exercise | | — | | | — | | | 2,989,887 | | | — | | | — | | | — | | | — |
| Issuance of common stock for conversions | | — | | | — | | | 1,845,945 | | | — | | | 1,545 | | | — | | | 1,545 |
| Issuance of common stock with NYIAX transaction | | — | | | — | | | 1,500,000 | | | — | | | — | | | — | | | — |
| Issuance of warrants with the 2025 Notes | | — | | | — | | | — | | | — | | | 16,657 | | | — | | | 16,657 |
| Issuance of common stock for the acquisition of CSI | | — | | | — | | | 10,600,000 | | | 1 | | | 10,282 | | | — | | | 10,283 |
| Equity issuance costs | | — | | | — | | | — | | | — | | | (137) | | | — | | | (137) |
| Net loss | | — | | | — | | | — | | | — | | | — | | | (37,116) | | | (37,116) |
| Balance as of June 30, 2025 | — | | | — | | 86,661,219 | | $7 | | $419,192 | | $(345,130) | | $74,069 | ||||||
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · · · · · · · · · · Total | ||||||||||||||||||||
| · · Convertible Preferred Stock · · · Common Shares · · Additional · · Accumulated · · Stockholders’ | ||||||||||||||||||||
| · Shares · · Amount · Shares · Amount · Paid-in Capital · Deficit · Equity (Deficit) | ||||||||||||||||||||
| Balance as of December 31, 2023 | | 38,335 | | $247 | | | 222,380 | | $1 | | $241,884 | | $(247,042) | | $(5,157) | |||||
| Stock-based compensation | | — | | | — | | | 4 | | | — | | | 380 | | | — | | | 380 |
| Cumulative effect of ASU 2020-06 adoption | | — | | | 116 | | | — | | | — | | | (116) | | | — | | | (116) |
| Issuance of Series B preferred stock in connection with warrant exercise, net of discounts | | 29,322 | | | 386 | | | — | | | — | | | — | | | — | | | — |
| Issuance of common stock in connection with conversion of Series B preferred stock | | (5,000) | | | (325) | | | 8,038 | | | — | | | 325 | | | — | | | 325 |
| Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock | | — | | | 5,842 | | | — | | | — | | | (5,842) | | | — | | | (5,842) |
| Repurchase of Series B preferred stock and Series B preferred stock warrants | | (62,657) | | | (6,266) | | | — | | | — | | | 824 | | | — | | | 824 |
| Issuance of common stock, pre-funded units and warrants, net of offering costs | | — | | | — | | | 1,442,518 | | | — | | | 4,210 | | | — | | | 4,210 |
| Issuance of common stock in connection with reverse split rounding-up for fractional shares | | — | | | — | | | 84,255 | | | — | | | — | | | — | | | — |
| Net income | | — | | | — | | | — | | | — | | | — | | | 2,707 | | | 2,707 |
| Balance as of March 31, 2024 | — | | | — | | | 1,757,195 | | $1 | | $241,665 | | $(244,335) | | $(2,669) | |||||
| Stock-based compensation | | — | | | — | | | 255,915 | | | — | | | 241 | | | — | | | 241 |
| Issuance of common stock in connection with warrant exercise | | — | | | — | | | 441,822 | | | — | | | 556 | | | — | | | 556 |
| Issuance of common stock and warrants, net of offering costs | | — | | | — | | | 2,466,583 | | | — | | | 8,756 | | | — | | | 8,756 |
| Issuance of common stock to vendors | | — | | | — | | | — | | | — | | | 360 | | | — | | | 360 |
| Restricted stock awards cancelled | | — | | | — | | | (82) | | | — | | | — | | | — | | | — |
| Release of vested restricted common stock | | — | | | — | | | 1 | | | — | | | — | | | — | | | — |
| Conversion of liability warrants to equity warrants | | — | | | — | | | — | | | — | | | 41,851 | | | — | | | 41,851 |
| Net loss | | — | | | — | | | — | | | — | | | — | | | (42,665) | | | (42,665) |
| Balance as of June 30, 2024 | | — | | | — | | | 4,921,434 | | $1 | | $293,429 | | $(287,000) | | $6,430 | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.